Alexander Davies, D.V.M., Ph.D., and his lab are part of the Knight Cancer Precision Biofabrication Hub that will allow cancer researchers to dissect the complexities of cancers through lab-grown tissues. (OHSU/Christine Torres Hicks)

Luiz Bertassoni, D.D.S., Ph.D., and his cancer research team stand outside the OHSU Knight Cancer Research Building. Bertassoni will lead a newly formed Knight Cancer Precision Biofabrication Hub that will allow cancer researchers to dissect the complexities of cancers through lab-grown tissues. (OHSU/Christine Torres Hicks)

Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer. (OHSU/Christine Torres Hicks)

A pancreatic cancer cell slide on a microscope. Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer. (OHSU/Christine Torres Hicks)

Brian Druker, M.D., receives the inaugural Knight Lifetime Achievement Award, presented by OHSU President Shereef Elnahal, M.D., M.B.A. The award is named for Nike founder Phil Knight, a longtime supporter of the OHSU Knight Cancer Institute. (OHSU/Christine Torres Hicks)

Brian Druker, M.D., receives the inaugural Knight Lifetime Achievement Award, presented by OHSU President Shereef Elnahal, M.D., M.B.A. The award is named for Nike founder Phil Knight, a longtime supporter of the OHSU Knight Cancer Institute. (OHSU/Christine Torres Hicks)